We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Proposed Combo Products Rule Underestimates Cost of GMPs
Proposed Combo Products Rule Underestimates Cost of GMPs
January 4, 2010
The FDA’s proposed rule on GMPs for combination products underestimates the burden of applying certain cGMP requirements to drug-device combinations, industry says.